June 25, 2017

Atrial Fibrillation & Anticoagulants–StopAfib.org interviews Dr. Elaine Hylek

StopAfib.org interviews Dr. Elaine Hylek of Boston University.
A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at:
http://www.stopafib.org/newsitem.cfm/NEWSID/349

In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) has been the only anticoagulant option for patients. Taking warfarin requires constant monitoring, and it can be a challenge for many patients. In addition to drug-drug interactions and food-drug interactions, warfarin can be affected by illness or heart failure. Dr. Hylek discusses the clinical trials results for two of the new anticoagulants that are alternatives to warfarin.

Dr. Hylek is the Director of Thrombosis and Anticoagulation Services at the Boston Medical Center, and is an Associate Professor at of Medicine at Boston University.

Comment